nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLCO1A2—Levothyroxine—hypothyroidism	0.277	0.336	CbGbCtD
Rocuronium—SLCO1A2—Liothyronine—hypothyroidism	0.277	0.336	CbGbCtD
Rocuronium—SLCO1A2—Liotrix—hypothyroidism	0.27	0.328	CbGbCtD
Rocuronium—CHRNA1—tongue—hypothyroidism	0.01	0.147	CbGeAlD
Rocuronium—Wheezing—Dextrothyroxine—hypothyroidism	0.00618	0.064	CcSEcCtD
Rocuronium—Wheezing—Levothyroxine—hypothyroidism	0.00618	0.064	CcSEcCtD
Rocuronium—HTR3A—nerve—hypothyroidism	0.0061	0.0891	CbGeAlD
Rocuronium—Arrhythmia—Liothyronine—hypothyroidism	0.00581	0.0602	CcSEcCtD
Rocuronium—Hypertension—Liothyronine—hypothyroidism	0.00489	0.0507	CcSEcCtD
Rocuronium—CHRND—heart—hypothyroidism	0.00458	0.0668	CbGeAlD
Rocuronium—Wheezing—Liotrix—hypothyroidism	0.00455	0.0471	CcSEcCtD
Rocuronium—Tachycardia—Liothyronine—hypothyroidism	0.00451	0.0467	CcSEcCtD
Rocuronium—Hypotension—Liothyronine—hypothyroidism	0.00432	0.0447	CcSEcCtD
Rocuronium—CHRND—cardiovascular system—hypothyroidism	0.00432	0.0631	CbGeAlD
Rocuronium—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00407	0.0422	CcSEcCtD
Rocuronium—Muscular weakness—Levothyroxine—hypothyroidism	0.00407	0.0422	CcSEcCtD
Rocuronium—CHRND—thyroid gland—hypothyroidism	0.0033	0.0481	CbGeAlD
Rocuronium—CHRNA2—heart—hypothyroidism	0.00317	0.0463	CbGeAlD
Rocuronium—Muscular weakness—Liotrix—hypothyroidism	0.003	0.031	CcSEcCtD
Rocuronium—CHRNB1—heart—hypothyroidism	0.00295	0.0431	CbGeAlD
Rocuronium—Bronchospasm—Liotrix—hypothyroidism	0.00289	0.0299	CcSEcCtD
Rocuronium—Arrhythmia—Levothyroxine—hypothyroidism	0.00285	0.0296	CcSEcCtD
Rocuronium—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00285	0.0296	CcSEcCtD
Rocuronium—CHRNA1—thyroid gland—hypothyroidism	0.00275	0.0402	CbGeAlD
Rocuronium—CHRNA2—blood—hypothyroidism	0.00236	0.0345	CbGeAlD
Rocuronium—CHRNA2—thyroid gland—hypothyroidism	0.00228	0.0333	CbGeAlD
Rocuronium—Shock—Dextrothyroxine—hypothyroidism	0.00223	0.0231	CcSEcCtD
Rocuronium—Shock—Levothyroxine—hypothyroidism	0.00223	0.0231	CcSEcCtD
Rocuronium—Tachycardia—Levothyroxine—hypothyroidism	0.00222	0.023	CcSEcCtD
Rocuronium—Tachycardia—Dextrothyroxine—hypothyroidism	0.00222	0.023	CcSEcCtD
Rocuronium—CHRNB1—adrenal gland—hypothyroidism	0.0022	0.0321	CbGeAlD
Rocuronium—CHRNB1—blood—hypothyroidism	0.0022	0.0321	CbGeAlD
Rocuronium—CHRNB1—thyroid gland—hypothyroidism	0.00212	0.031	CbGeAlD
Rocuronium—Arrhythmia—Liotrix—hypothyroidism	0.0021	0.0218	CcSEcCtD
Rocuronium—CHRNB1—female gonad—hypothyroidism	0.00205	0.03	CbGeAlD
Rocuronium—CHRM2—heart—hypothyroidism	0.00189	0.0276	CbGeAlD
Rocuronium—CHRNB1—testis—hypothyroidism	0.00182	0.0266	CbGeAlD
Rocuronium—CHRNA2—cerebellum—hypothyroidism	0.00181	0.0264	CbGeAlD
Rocuronium—CHRM2—cardiovascular system—hypothyroidism	0.00178	0.0261	CbGeAlD
Rocuronium—Hypertension—Liotrix—hypothyroidism	0.00177	0.0183	CcSEcCtD
Rocuronium—CHRNB1—liver—hypothyroidism	0.00172	0.0251	CbGeAlD
Rocuronium—HTR3A—blood—hypothyroidism	0.00169	0.0247	CbGeAlD
Rocuronium—CHRNB1—cerebellum—hypothyroidism	0.00168	0.0246	CbGeAlD
Rocuronium—Anaphylactic shock—Liotrix—hypothyroidism	0.00167	0.0173	CcSEcCtD
Rocuronium—Shock—Liotrix—hypothyroidism	0.00164	0.017	CcSEcCtD
Rocuronium—Tachycardia—Liotrix—hypothyroidism	0.00163	0.0169	CcSEcCtD
Rocuronium—Pruritus—Levothyroxine—hypothyroidism	0.00161	0.0166	CcSEcCtD
Rocuronium—Pruritus—Dextrothyroxine—hypothyroidism	0.00161	0.0166	CcSEcCtD
Rocuronium—Hypotension—Liotrix—hypothyroidism	0.00156	0.0162	CcSEcCtD
Rocuronium—Vomiting—Levothyroxine—hypothyroidism	0.00144	0.015	CcSEcCtD
Rocuronium—Vomiting—Dextrothyroxine—hypothyroidism	0.00144	0.015	CcSEcCtD
Rocuronium—Rash—Dextrothyroxine—hypothyroidism	0.00143	0.0148	CcSEcCtD
Rocuronium—Rash—Levothyroxine—hypothyroidism	0.00143	0.0148	CcSEcCtD
Rocuronium—Dermatitis—Levothyroxine—hypothyroidism	0.00143	0.0148	CcSEcCtD
Rocuronium—Dermatitis—Dextrothyroxine—hypothyroidism	0.00143	0.0148	CcSEcCtD
Rocuronium—SLC22A1—blood—hypothyroidism	0.00139	0.0202	CbGeAlD
Rocuronium—Nausea—Dextrothyroxine—hypothyroidism	0.00135	0.014	CcSEcCtD
Rocuronium—Nausea—Levothyroxine—hypothyroidism	0.00135	0.014	CcSEcCtD
Rocuronium—Hypersensitivity—Liotrix—hypothyroidism	0.00123	0.0127	CcSEcCtD
Rocuronium—Pruritus—Liotrix—hypothyroidism	0.00118	0.0122	CcSEcCtD
Rocuronium—SLCO1A2—testis—hypothyroidism	0.0011	0.0161	CbGeAlD
Rocuronium—SLC22A1—liver—hypothyroidism	0.00108	0.0158	CbGeAlD
Rocuronium—Vomiting—Liotrix—hypothyroidism	0.00106	0.011	CcSEcCtD
Rocuronium—Rash—Liotrix—hypothyroidism	0.00105	0.0109	CcSEcCtD
Rocuronium—Dermatitis—Liotrix—hypothyroidism	0.00105	0.0109	CcSEcCtD
Rocuronium—SLCO1A2—liver—hypothyroidism	0.00104	0.0152	CbGeAlD
Rocuronium—SLCO1A2—cerebellum—hypothyroidism	0.00102	0.0149	CbGeAlD
Rocuronium—Nausea—Liotrix—hypothyroidism	0.000992	0.0103	CcSEcCtD
Rocuronium—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.000665	0.0622	CbGpPWpGaD
Rocuronium—SLCO1A2—Transport of organic anions—AVP—hypothyroidism	0.000639	0.0598	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000541	0.0506	CbGpPWpGaD
Rocuronium—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.000508	0.0475	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000393	0.0367	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000349	0.0326	CbGpPWpGaD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000337	0.0315	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000334	0.0312	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000317	0.0297	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—SLC5A7—hypothyroidism	0.000301	0.0282	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000286	0.0268	CbGpPWpGaD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000272	0.0254	CbGpPWpGaD
Rocuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00026	0.0243	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—SLC5A7—hypothyroidism	0.000256	0.0239	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000253	0.0237	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—SLC5A7—hypothyroidism	0.000243	0.0227	CbGpPWpGaD
Rocuronium—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000237	0.0222	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000215	0.0201	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000204	0.0191	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0002	0.0187	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—NEFL—hypothyroidism	0.000194	0.0181	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—NEFL—hypothyroidism	0.000165	0.0154	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000162	0.0151	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—NEFL—hypothyroidism	0.000157	0.0147	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000149	0.0139	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000146	0.0136	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000139	0.013	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000134	0.0125	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000129	0.012	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000123	0.0115	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000118	0.0111	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.000112	0.0104	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	9.79e-05	0.00916	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	9.39e-05	0.00879	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.22e-05	0.00769	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	8.03e-05	0.00751	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—NEFL—hypothyroidism	7.2e-05	0.00673	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.81e-05	0.00637	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	6.47e-05	0.00605	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6e-05	0.00562	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.95e-05	0.00557	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	5.58e-05	0.00522	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—IYD—hypothyroidism	5.55e-05	0.0052	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	5.12e-05	0.00479	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	5.09e-05	0.00476	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	4.98e-05	0.00465	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	4.98e-05	0.00465	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.98e-05	0.00465	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ATP5O—hypothyroidism	4.72e-05	0.00442	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	4.72e-05	0.00442	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—AVP—hypothyroidism	4.69e-05	0.00438	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TPO—hypothyroidism	4.44e-05	0.00415	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—TRH—hypothyroidism	4.25e-05	0.00398	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.11e-05	0.00385	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—IYD—hypothyroidism	4.06e-05	0.0038	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	3.79e-05	0.00354	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	3.79e-05	0.00354	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	3.72e-05	0.00348	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ATP5O—hypothyroidism	3.45e-05	0.00323	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.29e-05	0.00307	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TPO—hypothyroidism	3.24e-05	0.00303	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	2.93e-05	0.00274	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.59e-05	0.00242	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	2.45e-05	0.00229	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	2.4e-05	0.00225	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.4e-05	0.00225	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—AVP—hypothyroidism	2.23e-05	0.00209	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TRH—hypothyroidism	2.18e-05	0.00204	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	2.14e-05	0.002	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	2.14e-05	0.002	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TSHB—hypothyroidism	2.06e-05	0.00192	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	1.95e-05	0.00182	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	1.94e-05	0.00182	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	1.94e-05	0.00182	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.89e-05	0.00177	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	1.83e-05	0.00171	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.81e-05	0.00169	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	1.54e-05	0.00144	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TSHB—hypothyroidism	1.5e-05	0.0014	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CLTC—hypothyroidism	1.49e-05	0.00139	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—POMC—hypothyroidism	1.48e-05	0.00139	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	1.34e-05	0.00125	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	1.31e-05	0.00123	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TRH—hypothyroidism	1.29e-05	0.00121	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	1.26e-05	0.00118	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	1.19e-05	0.00111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TSHB—hypothyroidism	1.15e-05	0.00107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TSHR—hypothyroidism	1.15e-05	0.00107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AVP—hypothyroidism	1.15e-05	0.00107	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC5A5—hypothyroidism	1.12e-05	0.00105	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	1.02e-05	0.000958	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	8.39e-06	0.000785	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—POMC—hypothyroidism	8.05e-06	0.000753	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—POMC—hypothyroidism	7.61e-06	0.000712	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRL—hypothyroidism	7.59e-06	0.000711	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VAV3—hypothyroidism	7.03e-06	0.000657	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AVP—hypothyroidism	6.77e-06	0.000633	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—POMC—hypothyroidism	5.88e-06	0.00055	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—POMC—hypothyroidism	4.5e-06	0.000421	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1—hypothyroidism	4.33e-06	0.000405	CbGpPWpGaD
